TELA Bio (TELA) Change in Account Payables (2018 - 2026)
TELA Bio's (TELA) quarterly Change in Account Payables came in at $1.6 million in Q1 2026, down 14.03% year-on-year from $1.9 million in Q1 2025, and up 2628.57% quarter-over-quarter from -$63000.0 in Q4 2025.
TELA Bio (TELA) Change in Account Payables (2018 - 2026) Analysis & Trends
TELA Bio's Change in Account Payables history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 14.03% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was -$119000.0, a 114.51% decrease from a year earlier, with the FY2025 full-year figure at $141000.0, down 70.75% from the prior year.
- Change in Account Payables improved to $1.6 million in Q1 2026 per TELA's latest filing, from -$63000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.7 million in Q1 2023 and bottomed at -$3.7 million in Q2 2022.
- The 5-year median for Change in Account Payables is $42000.0 (2024), against an average of $79000.0.
- Across the five-year window, Change in Account Payables plunged 28963.64% in 2022 and jumped 1452.38% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$3.2 million in 2022, then soared by 52.0% to -$1.5 million in 2023, then surged by 89.9% to -$154000.0 in 2024, then soared by 59.09% to -$63000.0 in 2025, then jumped by 2628.57% to $1.6 million in 2026.
- Per Business Quant, the three latest TELA Change in Account Payables figures stand at $1.6 million (Q1 2026), -$63000.0 (Q4 2025), and $652000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | TELA Bio | 38.36 Mn | -1.18 Mn | 12.52 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | 652,000.00 |
| Sep 30, 2025 | 652,000.00 |
| Jun 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | -154,000.00 |
| Dec 31, 2024 | -154,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | -921,000.00 |
| Jun 30, 2024 | -921,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | -1.52 Mn |
| Dec 31, 2023 | -1.52 Mn |